Roche Holding AG (RHHBY)
60.58
+0.61
(+1.02%)
USD |
OTCM |
Feb 24, 16:33
Roche Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Novartis AG | 2.837B |
| AstraZeneca PLC | 3.725B |
| Gilead Sciences, Inc. | 1.565B |
| GSK Plc | 3.112B |
| Eli Lilly & Co. | 3.802B |